Skip to main content

Table 1 Clinical and biochemical characteristics of each group patientsa

From: Association of TM6SF2 rs58542926 gene polymorphism with the risk of non-alcoholic fatty liver disease and colorectal adenoma in Chinese Han population

Characteristic NAFLD
(n = 201)
NAFLD&CRA
(n = 188)
CRA
(n = 211)
Control
(n = 239)
Age (yr) 54.80 ± 0.56 54.60 ± 0.48 55.10 ± 0.52 54.00 ± 0.78
BMI (kg/m2) 24.56 ± 1.28* 25.45 ± 2.07* 24.12 ± 1.43* 23.05 ± 0.67
CAP (dB/m) 242.56 ± 31.42*@ 245.64 ± 29.63*@ 230.66 ± 32.33* 201.23 ± 28.67
FPG (mmol/L) 5.01 ± 0.45* 5.24 ± 0.89* 5.09 ± 0.78* 4.78 ± 0.99
TC (mmol/L) 5.49 ± 0.95 5.56 ± 0.87 5.46 ± 0.78 5.43 ± 0.79
TG (mmol/L) 1.96 ± 1.23* 1.98 ± 1.34* 1.89 ± 1.27* 1.48 ± 1.06
LDL-C (mmol/L) 3.32 ± 0.45 3.31 ± 0.79 3.28 ± 0.67 3.20 ± 0.77
HDL-C (mmol/L) 1.33 ± 0.32 1.32 ± 0.37 1.37 ± 0.56 1.38 ± 0.41
AST (U/L) 39.60 ± 8.30* 40.50 ± 9.2*@ 34.50 ± 8.50 31.40 ± 7.30
ALT (U/L) 37.20 ± 9.90*@ 39.90 ± 10.30* 31.80 ± 11.90 30.90 ± 10.10
UA (μmol/L) 368.76 ± 80.32* 370.58 ± 67.92* 369.61 ± 84.26* 340.56 ± 75.67
  1. Abbreviations: NAFLD non-alcoholic fatty liver disease, CRA colorectal adenoma, BMI body mass index, CAP controlled attenuation parameter, FPG fasting plasma glucose, TC total cholesterol, TG triglyceride, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, AST aspartate aminotransferase, ALT alanine aminotransferase, UA uric acid
  2. *compared with the control group, P < 0.05; @ compared with CRA group, P < 0.05
  3. aData are presented as mean ± SD